Edited by Richard L. Huganir, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved February 20, 2014 (received for review March 7, 2013) The GluA2 subunit of AMPA-type glutamate receptors (AMPARs) regulates excitatory synaptic transmission in neurons. In addition, the transsynaptic cell adhesion molecule N-cadherin controls excitatory synapse function and stabilizes dendritic spine structures. At postsynaptic membranes, GluA2 physically binds N-cadherin, underlying spine growth and synaptic modulation. We report that N-cadherin binds to PSD-95/SAP90/DLG/ZO-1 (PDZ) domain 2 of the glutamate receptor interacting protein 1 (GRIP1) through its intracellular C terminus. N-cadherin and GluA2-containing AMPARs are presorted to identical transport vesicles for dendrite delivery, and live imaging reveals cotransport of both proteins. The kinesin KIF5 powers GluA2/N-cadherin codelivery by using GRIP1 as a multilink interface. Notably, GluA2 and N-cadherin use different PDZ domains on GRIP1 to simultaneously bind the transport complex, and interference with either binding motif impairs the turnover of both synaptic cargoes. Depolymerization of microtubules, deletion of the KIF5 motor domain, or specific blockade of AMPAR exocytosis affects delivery of GluA2/N-cadherin vesicles. At the functional level, interference with this cotransport reduces the number of spine protrusions and excitatory synapses. Our data suggest the concept that the multi-PDZ-domain adaptor protein GRIP1 can act as a scaffold at trafficking vesicles in the combined delivery of AMPARs and N-cadherin into dendrites.
A ctive vesicle transport regulates various cellular processes through delivery, recycling, and removal of plasma membrane proteins (1) . In neurons, the rapid turnover of hundreds of synaptic molecules including neurotransmitter receptors and cell adhesion molecules is critical for synapse formation and function (2) . AMPA-type glutamate receptors (AMPARs) are key players in this context, participating in excitatory transmission and longterm plasticity (the ability of individual synapses to persistently change in strength) (3, 4) . Synaptic plasticity includes structural changes such as an enlargement of spines or postsynaptic densities (PSDs) and is often accompanied by an augmented trafficking of synaptic cargoes (2, 5) . N-cadherin has been shown to critically stabilize the pre-and postsynaptic connection, both in synaptogenesis and during activity-dependent growth of synaptic contacts (6) . In agreement with AMPARs and N-cadherin being involved in functional and structural synaptic plasticity, an interaction between their extracellular domains at the surface membrane was reported (7, 8) that stimulates presynaptic development and dendritic spine formation.
For anterograde delivery to dendritic spines, GluA2 directly interacts with the multi-PDZ-domain protein glutamate receptor interacting protein 1 (GRIP1), which in turn directly binds the kinesin motor protein KIF5 (9) (10) (11) (12) . GRIP1 is expressed in various tissues, harbors seven PDZ domains, and interacts with different transmembrane proteins underlying vesicle trafficking or membrane localization (13) (14) (15) (16) .
Here we report that through a direct interaction with GRIP1, N-cadherin already associates with AMPARs at KIF5C-driven vesicles. Transport adaptors are suggested to organize presorting of intracellular proteins, leading to subpopulations of transport vesicles with a unique identity.
Results N-Cadherin Binds GRIP1 and KIF5C. We screened for new interaction partners of PDZ domains 1-3 of GRIP1, using the yeast two-hybrid system. Two clones encoding amino acids (aa) 102-906 of N-cadherin were identified ( (Fig. 1C) . Because GRIP1 acts as a cargo adapter at KIF5-driven AMPAR vesicles (12), we asked whether KIF5 interacted with N-cadherin/GRIP1 associations. Co-IPs of either XFP-fusion proteins from 3T3 and HEK293 cells (Fig.  1D and Fig. S1D ) or by using vesicle-enriched brain lysate (Fig. 1E ) indeed detected triple association of N-cadherin with KIF5C and its cargo adaptor GRIP1. Accordingly, coimmunostainings in hippocampal neurons indicated colocalization of N-cadherin and GRIP1 in dendrites (Fig. S2A) , with colocalization levels of ∼72% at spine and shaft synapses and ∼61-68% at nonsynaptic sites, containing various proteins in transit (Fig. 1 F and G) .
Significance
Synapses form and change in response to neuronal activity, and they dynamically exchange transmembrane proteins over time. Most synaptic proteins are synthesized in the cell body and undergo long-distance vesicular transport powered by molecular motors along microtubules. Here we show that two synaptic key proteins (GluA2 and N-cadherin) are simultaneously delivered within distinct transport vesicles through motor proteins. Our data suggest that multidomain cargo adaptors tether synaptic proteins destined for the same subcellular compartment. We propose that vesicular presorting is an alternative mechanism to efficiently supply synapses.
In agreement with KIF5C mediating long-distance dendrite delivery (2) , N-cadherin and KIF5C puncta colocalized within dendrite shafts (∼52-54%) (Fig. S2 B and C) , suggesting KIF5C-driven transport of N-cadherin-containing vesicles. Notably, KIF5C/ N-cadherin colocalization in turn significantly decreased through competitive overexpression of the PDZ2 domain of GRIP1 that harbors the N-cadherin binding motif ( Fig. 1 H and I) . Together, this indicates that PDZ2 of GRIP1 connects N-cadherin to the kinesin motor protein KIF5C.
Dendrite Delivery of N-Cadherin and GRIP1 Depends on KIF5C. Because the trafficking of N-cadherin in differentiated neurons remained unclear, although activity-dependent delivery of other synaptic proteins depends on KIF5 (17), we analyzed GRIP1 and N-cadherin transport in neurons at later developmental stages [9] [10] [11] [12] ]. Because endogenous proteins were already synaptically localized, similarly distributing XFP-fusion proteins of GRIP1 and N-cadherin (Fig. S3) (18, 19) were used to monitor dendrite delivery. Monomeric red fluorescent protein (mRFP)-GRIP1 and mRFP-N-cadherin (mRFP-NCAD) particles were highly delivered into dendrites in the presence of GFP-KIF5C; however, they accumulated as large clusters in the cell soma on interference with KIF5C transport, using a dominant-negative KIF5C mutant lacking the motor domain (GFP-KIF5CΔMD) (Fig. 2 A-F and Fig. S4 A-F) . To test whether KIF5C also powers N-cadherin delivery to the plasma membrane, we labeled cell surface populations of N-cadherin in hippocampal neurons. Surface levels of newly synthesized mRFP-NCAD at dendrite segments were strongly increased on GFP- Reduced mRFP-NCAD mobility on GFP-KIF5CΔMD (44.6 ± 4.7%) compared with GFP coexpression (63.5 ± 3.4%); immobile population: GFP (36.5 ± 3.4%) and GFP-KIF5CΔMD (55.2 ± 4.7%) (n = 32). Data represent mean ± SEM. Statistical analysis, Student t test (***P < 0.001; **P < 0.01; *P < 0.05).
KIF5C but significantly reduced after GFP-KIF5CΔMD coexpression (Fig. 2 G-J and Fig. S4 G-I) . Moreover, cell surface biotinylation in HEK293 cells revealed decreased mRFP-NCAD surface levels on treatment with the microtubule depolymerizing agent nocodazole (Fig. 2K) , indicating that intact microtubules are a prerequisite for N-cadherin plasma membrane delivery. In addition, GFP-KIF5CΔMD significantly reduced mRFP-NCAD surface levels (Fig. 2L ), mimicking our observation from neurons. In video microscopy experiments, a frequent anterograde mobility of mRFP-NCAD particles over distances of several micrometers was observed (Fig. 2M ). Notably, quantitative particle tracking revealed that GFP-KIF5CΔMD coexpression significantly decreased the level of mobile mRFP-NCAD particles, whereas it increased the immobile particle population (Fig. 2 N and O and Movies S1 and S2). Together, we conclude that the anterograde delivery of N-cadherin in differentiated neurons at least partially depends on KIF5C. KIF5C pilots GluA2-containing AMPARs into dendrites, using GRIP1 as a cargo adaptor (12) . Because GRIP1 binds GluA2 through PDZ domains 4 and 5 (PDZ4,5), whereas it binds N-cadherin via PDZ2 (Fig. 1A) , we asked whether the three proteins may interact simultaneously, in particular as both cargoes head for excitatory synapses.
GFP-GluA2 displayed co-IP with mRFP-NCAD from HEK293 cells (Fig. S5A ) and endogenous GluA2 coprecipitated with N-cadherin and vice versa, using vesicle-enriched brain lysate (Fig. 3 A and B) . Both N-cadherin and GluA2 also coprecipitated with GRIP1, suggesting an intracellular triple association (Fig. 3C) . Accordingly, immunolabeling in hippocampal neurons indicated colocalization of N-cadherin and GluA2 in dendrites (Fig. S5B) , with colocalization levels of ∼71-75% at spine and shaft synapses and ∼60-65% at nonsynaptic sites containing various proteins in transit (Fig. 3D and Fig. S5 C and D) . In addition, GRIP1 puncta colocalized with N-cadherin/GluA2 associations within dendrite shafts (∼43-47%) (Fig. 3E and Fig. S5E) . As a control, we tested the dependence of GluA2 surface delivery on KIF5C function. Similar to N-cadherin (Fig. 2 J and L) , mCherry-KIF5CΔMD significantly reduced the amount of cell surface GluA2 in neurons (Fig. S5 F-H) . Co-IPs therefore aimed to analyze whether GRIP1 physically connects AMPARs with N-cadherin. Indeed, N-cadherin coprecipitated significantly higher amounts of GluA2 in the presence of GFP-GRIP1 compared with GFP (Fig. 3 F and G) , suggesting that the multi-PDZ domain protein GRIP1 bridges N-cadherin and GluA2 in the formation of a common vesicular transport complex.
Dynamic AMPA Receptor/N-Cadherin Transport Vesicles. To provide further evidence for a combined AMPAR/N-cadherin transport complex, we analyzed their occurrence at intracellular vesicles. Using electron microscopy (EM), double immunogold labeling revealed a close proximity of GluA2 and N-cadherin immunoreactivity not only at synapses but also at intracellular Golgi membranes and at small vesicles from both somatic and dendritic areas (Fig. 4 A and B and Fig. S6 A-D) . Quantification of immunogold particles at Golgi near regions revealed considerable amounts (∼22-28%) of vesicles that were double-labeled for GluA2 and N-cadherin (Fig. 4 A-C) . Moreover, quantitative video microscopy confirmed that ∼22% of GFP-GluA2 and mRFP-NCAD particles were cotransported in anterograde directions over distances of several micrometers (Fig. 4 D-F and Movie S3). In addition, we performed immunopurification of intracellular vesicles in the absence of detergent and analyzed them by EM and Western blotting (Fig. 4 G-J). Notably, vesicles immunoisolated with N-cadherin-specific antibodies harbored GluA2 within their membrane but were devoid of the cation channel transient receptor potential channel 1 (TRPC1) and Synaptophysin (used as controls). Accordingly, GluA2 was detected at N-cadherin-containing membranes on subsequent abrogation of protein-protein interactions through high pH treatment, which maintains the membrane integrity (Fig. 4K) . Importantly, N-cadherin and GluA2 remained in physical association with GRIP1 and KIF5C when vesicle membranes were solubilized (Fig. 4L) , indicating a common motor-cargo complex at distinct vesicle membranes. In this respect, we hypothesized that adaptor proteins such as GRIP1 can serve as multilink interfaces to specify and promote combined vesicle transport (e.g., of AMPAR/N-cadherin vesicles).
The Interdependence of AMPAR/N-Cadherin Trafficking Involves GRIP1.
To test for an interdependence of both cargoes in transit and whether this involves GRIP1, we used PDZ domain fragments to compete with binding of N-cadherin or GluA2 to GRIP1 (Fig. 4M ). Interestingly, a biotinylation approach revealed that overexpression of the N-cadherin binding site of GRIP1 (GFP-GRIP1-PDZ2) caused a significant cell surface reduction not only of N-cadherin but also of GluA2 (Fig. 5 A and B) . Reciprocal overexpression of the GluA2 binding site of GRIP1 (GFP-GRIP1-PDZ4,5) accordingly lowered not only GluA2 but also N-cadherin at the cell surface ( Fig. 5 C and D) . To substantiate the functional relevance of the coexistence of AMPAR and N-cadherin at neuronal transport vesicles, we further used a peptide sequence (Pep2m) known to specifically interrupt GluA2 binding to N-ethylmaleimide-sensitive fusion protein, which is required for AMPAR exocytosis (20) . Indeed, surface stainings revealed significantly reduced GluA2 signals on Pep2m overexpression compared with Pep4c (control) (Fig. 5 E-G) . Notably, the same approach caused a similar reduction in N-cadherin surface levels, indicating that at least a certain population of AMPARcontaining vesicles enters the plasma membrane together with N-cadherin. Moreover, at the level of motor-cargo interactions, competitive interference with N-cadherin-GRIP1 binding through either GFP-GRIP1-PDZ2 or GFP-NCAD-dn (harboring the GRIP1 binding site of N-cadherin; Fig. S1B ) lowered GluA2/ KIF5C colocalization in dendrites (Fig. 5 H and I) . In contrast, interference with GluA2-GRIP1 binding through either GFP-GRIP1-PDZ4,5 or GFP-GluA2-dn (harboring the GRIP1 binding site of GluA2) (9, 21) significantly reduced N-cadherin/ KIF5C colocalization (Fig. 5 J and K) . Our data suggest that the simultaneous binding of both cargo proteins to GRIP1 facilitates their plasma membrane targeting via KIF5C-mediated vesicle transport.
Coupled AMPAR/N-Cadherin Trafficking Is Critical for Neuronal
Connectivity. Because N-cadherin is critical for the development and stabilization of dendritic spines (6), we analyzed the numbers of dendritic protrusions on interference with KIF5C motor activity or after competitive interference of either GluA2-or N-cadherin binding to GRIP1. Using mRFP as a volume marker, neurons overexpressing GFP-KIF5CΔMD, GFP-GRIP1-PDZ2, or GFP-GRIP1-PDZ4,5 showed significantly reduced numbers of dendritic protrusions (Fig. 6 A-E). Together with our previous results, this suggests that AMPAR/N-cadherin vesicle codelivery through GRIP1/KIF5C promotes spine development.
As a consequence, the quantitative analysis of excitatory synapse numbers (represented by colocalization of presynaptic Synaptophysin and postsynaptic PSD-95) revealed a significant loss of synaptic contacts in the presence of either GFP-GRIP1-PDZ2 or GFP-GRIP1-PDZ4,5 compared with GFP (Fig. 6 F and  G) . In summary, we conclude that subpopulations of AMPARs and N-cadherin use GRIP1 as multilink interface to undergo KIF5C-driven vesicular cotransport with consequences for dendritic spine integrity and synaptic connectivity.
Discussion N-cadherin employs a p120-catenin/KIF5C complex for transport in fibroblasts (22) and a β-catenin/KIF3 complex during neural progenitor development (23, 24) . Our data show that in GFP-GRIP1-PDZ2 lowers NCAD (1.02 ± 0.15; n = 7) and GluA2 (0.62 ± 0.13; n = 5) surface levels compared with GFP-GRIP1 (1.60 ± 0.22 and 1.38 ± 0.13, respectively). (C and D) GFP-GRIP1-PDZ4,5 reduces GluA2 (0.70 ± 0.08; n = 8) and NCAD (0.61 ± 0.12; n = 6) surface levels compared with GFP-GRIP1 (1.30 ± 0.08 and 1.39 ± 0.12, respectively). (E-G) Surface immunostainings in DIV9-12 neurons. Reduced GluA2 and NCAD intensities (0.79 ± 0.02 and 0.78 ± 0.02) on pcDNA3-Pep2m compared with pcDNA3-Pep4c coexpression (set to 1). Numbers of cells as indicated. (Scale bars, 5 μm.) (H-K) Immunostaining of DIV9-12 hippocampal neurons (KIF5C pseudocolored). (H and I) GluA2/KIF5C colocalization levels (arrows) are reduced on GFP-GRIP1-PDZ2 (0.68 ± 0.02) or GFP-NCAD-dn (0.77 ± 0.02) compared with GFP expression (set to 1). (J and K) NCAD/KIF5C colocalization levels (arrows) are reduced on GFP-GRIP1-PDZ4,5 (0.74 ± 0.03) or GFP-GluA2-dn (0.69 ± 0.02) compared with GFP expression (set to 1). Numbers of cells as indicated. (Scale bar, 5 μm.) Data represent mean ± SEM. Statistical analysis, Student t test (***P < 0.001; **P < 0.01; *P < 0.05). differentiated neurons, GRIP1/KIF5C is involved in the proper delivery of N-cadherin into dendrites. Therefore, N-cadherin may use alternative transport factors, depending on the developmental stage or the destined subcellular destination. In support of this, the binding sites of catenins and GRIP1 map to separate regions on N-cadherin.
In addition, our study reveals AMPAR/N-cadherin cotransport and offers mechanistic insights into its organization through the adaptor protein GRIP1. Previous studies reported that axonal trafficking organelles in general could contain multiple cargoes (25) (26) (27) . TrkB, for instance, is transported with synaptic vesicle precursors to function in synapse formation (28) . Other reports suggest that linker proteins connect cell adhesion molecules on the plasma membrane to intracellular transport vesicles to allow for a direct supply to nascent synapses after initial contact formation (29, 30) . For example, Neuroligin1 at the cell surface is linked to NMDA receptor-containing vesicles via membrane-associated guanylate kinases and surface NCAM to post-Golgi organelles via Spectrin (29, 30) . However, this cotrafficking of surface and vesicle proteins differs from the transport complex described here, which represents the trafficking of multiple cargoes within a single vesicle.
Regarding this, a recent study showed that the proper assembly of synaptic vesicle precursors requires the presence of two core components, Piccolo and Bassoon (31) . Unfortunately, the molecular processes by which the multiple cargoes are selected and further linked to motor proteins to target specific subcellular destinations largely remain unknown. We suggest a mechanism by which a multi-PDZ domain protein (GRIP1) serves as a multilink interface to tether cargoes within one vesicle and to connect it to the respective motor protein. In contrast to the above-mentioned function of cotransported surface/vesicle proteins in synapse formation, intracellular codelivery of AMPAR with N-cadherin might represent an efficient option to approach the increasing demands of synaptic proteins during later developmental stages; however, this remains to be directly observed.
Considering that GluA2 and N-cadherin codelivery involves a distinct population of transport vesicles, both factors should also independently reach the cell surface in other vesicle populations. The composition of different vesicles might vary, depending on the specific needs of the acceptor compartment; for instance, during synaptic activity changes.
In this respect, AMPAR/N-cadherin vesicles could harbor additional cargoes such as the scaffolding molecule δ-catenin that anchors GluA2 and N-cadherin at synaptic sites (32) . In addition, the extracellular interaction of GluA2 and N-cadherin (7), if it takes place inside the vesicle lumen, could strengthen the stability of the complex.
Further studies should clarify whether AMPAR/N-cadherin codelivery contributes to the differentiation or to plastic changes of synapses and whether it exclusively applies to post-Golgi transport or to endocytic recycling processes as well. Our data suggest that multidomain adaptor proteins play important roles in providing vesicle identity and in the combined delivery of functionally associated key molecules.
Materials and Methods
Constructs and Antibodies. All constructs were verified by dideoxy sequencing. For details on plasmids, construction of mutants, and antibodies, see SI Materials and Methods.
Yeast Two-Hybrid Screening. The Matchmaker LexA Yeast Two-Hybrid system (Clontech) and a rat brain cDNA library (Origene) were used for proteinprotein interaction screening. Interaction of bait (pGilda) and prey (pJG4-5) fusions were assayed by activation of the LEU2 and lacZ reporter genes, as previously described (33) .
Cell Culture and Transfection. Primary cultures of hippocampal neurons were prepared from mice at embryonic day 16 or postnatal day 0 (P0), as described (33) . Cells were transfected with a calcium phosphate coprecipitation method (33) . See SI Materials and Methods.
Differential Centrifugation and Vesicle Immunoisolation. Whole mouse brains (P9-12) were homogenized and subjected to subsequent centrifugation steps. Antibody-coated Dynabeads M280 sheep anti mouse (Invitrogen) were used for immunopurification of vesicles (27) . See SI Materials and Methods.
Immunocytochemistry and EM. For postembedding immunogold labeling, ultrathin cryosections (70 nm) from hippocampus were cut and labeled. CA1 hippocampal neurons were examined using a Zeiss EM 902 (Carl Zeiss). See SI Materials and Methods.
Surface Biotinylation Assay. Cell surface expressed molecules were labeled with biotinamido-hexanoic acid 3-sulfo-N-hydroxysuccinimid-ester (Sigma) and precipitated with Dynabeads Myone TM Streptavidin C1 (Invitrogen). See SI Materials and Methods.
Time-lapse Video Microscopy, Image Processing, and Statistical Analysis. During live imaging, transfected hippocampal neurons (DIV13-14) were temperature-controlled (37°C) and CO 2 -controlled. Images were acquired using Spinning Disk (Tonegawa) live cell confocal technology (Visitron Systems). Live cell confocal technology was combined with two charge-coupled device EM cameras (Hamamatsu Photonics) and equipped with an optical image splitter for simultaneous dual image acquisition. See SI Materials and Methods.
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Supporting Information
Heisler et al. 10 .1073/pnas.1304301111 SI Materials and Methods Constructs. Sequences coding for PSD-95/SAP90/DLG/ZO-1 (PDZ) domain PDZ1 (aa1-154), PDZ2 (aa140-256), PDZ3 (aa242-473), and PDZ1-3 (aa1-473) of glutamate receptor interacting protein 1 (GRIP1) were separately subcloned as an EcoRI-SalI fragment into pGilda (Origene) and used as bait for yeast two-hybrid analysis. A truncated form of N-cadherin containing aa102-906 was subcloned as an EcoRI-XhoI fragment into pJG4-5 (Origene) and used as prey for yeast two-hybrid analysis. Additional truncation mutants (aa747-906, aa752-774, aa775-791, aa792-811, aa812-847, or 848-906) of N-cadherin were amplified from pJG4-5-N-cadherin-aa102-906 and cloned into pJG4-5 as EcoRI-XhoI fragments. The kinesin motor protein KIF5C construct fused with GFP (GFP-KIF5C) was a kind gift from Michelle Peckham (University of Leeds, Leeds, United Kingdom).
For the plasmid encoding a dominant-negative KIF5C with truncated motor domain (GFP-KIF5CΔMD), aa322-956 of KIF5C were amplified from a rat brain cDNA library and subcloned as a HindIII-KpnI fragment into the EGFP-C3 vector (Clontech). To generate pmCherry-KIF5C and pmCherry-KIF5CΔMD, the mCherry sequence was amplified from pmCherry (Clontech), and GFP sequences of either GFP-KIF5C or GFP-KIF5CΔMD were replaced by the mCherry sequence, using AgeI and SacI restriction sites.
For GFP-GRIP1, full-length GRIP1 cDNA was amplified from a rat brain cDNA library and cloned into the EGFP-C1 vector (Clontech) as a BglII-SalI fragment. The mRFP sequence was amplified from pmRFP-N1 (a kind gift from Roger Tsien, Department of Pharmacology, Department of Chemistry and Biochemistry, University of California, San Diego, CA) as an AgeIEcoRI fragment and exchanged with the EGFP fragment in GFP-GRIP1 [monomeric red fluorescent protein (mRFP)-GRIP1]. To generate GFP-GRIP1-PDZ2 and GFP-GRIP1-PDZ4-5, nucleotides coding for aa140-256 (PDZ2) or aa441-655 (PDZ4-5) of GRIP1 were amplified from a rat brain cDNA library and cloned as BglII-PstI and HindIII-KpnI fragments into pEGFP-C1 (Clontech), respectively. To generate GFP-GluA2-dn, nucleotides coding for aa853-883 (C terminus, compare with refs. 1 and 2) of GluA2 were amplified from pEGFP-GluA2 and cloned as a SacISall fragment into pEGFP-C1 (Clontech). To generate mRFP-Ncadherin, the mRFP sequence was amplified from pmRFP-N1 and used to replace the Venus sequence in pCXN2-N-cadherin-Venus (a kind gift from Hidekazu Tanaka, Department of Pharmacology, Osaka University Medical School, Osaka, Japan), using XhoI and BglII restriction sites. To generate GFP-N-cadherin-dominant negative (NCAD-dn), nucleotides coding for aa775-791 on Ncadherin were subcloned from pJG4-5-N-cadherin-aa775-791 into pEGFP-C2 as an EcoRI-XhoI fragment.
The GluA2 construct fused to Myc and GFP (GFP-GluA2) was a kind gift from Peter Seeburg (Max Plank Institute for Medical Research, Heidelberg, Germany). The GluA2 construct fused to GFP used for live imaging experiments (GFP-GluA2) was a kind gift from Daniel Choquet (Interdisciplinary Institute for Neuroscience, Bordeaux, France). All constructs were verified by dideoxy sequencing. The following antibodies were used for immunofluorescence: mouse anti-GluA2 (1:1,000; Chemicon); rabbit anti-GRIP1 (1:1,000; Upstate, Lake Placid); goat anti-GRIP1 (1:25; Santa Cruz Biotechnology); rabbit anti-KIF5C (1:1,000; Thermo Scientific); mouse anti-MAP2 (1:5,000; Sigma); mouse anti-N-cadherin (1:1,000; BD Biosciences); mouse anti-N-cadherin (1:1,000; Sigma); rabbit anti-N-cadherin (1:100; Cell Signaling Technologies); rabbit anti-Rab6A (1:100; Sigma); mouse anti-synaptic vesicle (SV2, 1:500; Hybridoma Bank); guinea pig anti-Synaptophysin (1:1,000; Synaptic Systems); Alexa Fluor 488 conjugated donkey antimouse and donkey anti-rabbit (both 40μg/mL; Invitrogen); CY3-or CY5-conjugated donkey anti-mouse or donkey anti-rabbit (all 1:1,000; Dianova).
Yeast Two-Hybrid Screening. The Matchmaker LexA Yeast TwoHybrid system (Clontech) and a rat brain cDNA library (Origene) were used for protein-protein interaction screening. Interaction of bait (pGilda) and prey (pJG4-5) fusions were assayed by activation of the LEU2 and lacZ reporter genes, as previously described (3) . Plasmid DNA of positive clones was recovered, and inserts were analyzed by dideoxy sequencing.
Cell Culture and Transfection. Primary cultures of hippocampal neurons were prepared from mice at P0 or E16, as previously described (4) . Cells cultured between 9 and 12 d in vitro (DIV9-12) were used for transfection with a calcium phosphate coprecipitation method (4). HEK293 cells were grown to 60% confluency before transfection, using the calcium phosphate coprecipitation protocol.
Differential Centrifugation and Coimmunoprecipitation. Mice or rat brains of five P10 animals were dissected in ice-cold PBS and homogenized in IM-Ac buffer (20 mM Hepes, 100 mM KCl, 5 mM EGTA, and 5 mM MgCl 2 at pH 7.2) with freshly added protease inhibitor mixture (Roche), 1 mM PMSF, 5 mM DTT, and 2 mM Mg-ATP (all Sigma). The homogenate was centrifuged at 1,000 × g for 10 min, and the resulting postnuclear supernatant further was clarified at 10,000 × g for 10 min. The resulting supernatants were processed by another 100,000 × g centrifugation step for 1 h to collect a pellet (P3), typically enriched with small intracellular vesicles (5) . Two-to 4-μg antibodies were coupled to magnetic Protein G Dynabeads (Invitrogen) at 4°C for 4 h with constant rotating. Brain extracts from P3 fractions or HEK293 cell extracts were incubated with antibody-conjugated beads overnight, followed by extensive washing steps with IM-Ac buffer (20 mM Hepes, 100 mM KCl, 5 mM EGTA, and 5 mM MgCl 2 at pH 7.2) or IP buffer (150 mM NaCl, 50 mM Tris at pH 7.5, 5 mM MgCl 2 ), respectively, containing 0.5-1.0% Triton X-100. Bound proteins were eluted in SDS sample buffer, subjected to SDS/PAGE, and analyzed by Western blotting.
Vesicle Immunoisolation. Subcellular fractionation with subsequent immunopurification of vesicles carrying specific transmembrane proteins was performed as previously described (6, 7) . In brief, whole mouse brains (P9-12) were homogenized in ice-cold sucrose buffer (320 mM sucrose, 10 mM Hepes, 5 mM EDTA at pH 7.3) freshly supplemented with protease inhibitor mixture (Roche) and 1 mM PMSF. Homogenates were centrifuged at 12,500 × g for 8 min, and the resulting supernatants were again centrifuged at 40,000 × g for 40 min. Next, supernatants were recovered and centrifuged at 120,000 × g for 1 h. The obtained pellet was resuspended in sucrose buffer and subjected to another centrifugation step at 120,000 × g for 1 h. To promote resuspension, the resulting pellet (V1 C ) was vigorously stirred for 1 h before immunopurification. Dynabeads M280 sheep antimouse (Invitrogen) were washed twice with 0.1% BSA in PBS, incubated with antibodies (5 μg each in 0.1% BSA in PBS) for 1 h with constant rotating, and washed twice with 0.1% BSA in PBS, once with elution buffer (20 mM Tris at pH 7.4, 0.1% Triton X-100), and four times with IP buffer (PBS, 320 mM sucrose, 5 mM EDTA) supplemented with protease inhibitor mixture (Roche) and 1 mM PMSF. V1
C vesicle fractions were incubated with antibody precoated beads for 2 h on a rotation wheel and washed 18-22 times with IP buffer. For electron microscopy studies, magnetic beads were collected by brief centrifugation, and the pellet was fixed in 4% (wt/vol) PFA and 0.1% (wt/vol) Glutaraldehyde in IP buffer. Further processing of beads was carried out as described in SI Electron Microscopy. For Western blot analysis without interfering with protein-protein interactions, beads were washed with 20 mM Tris at pH 7.4 and solubilized for 30 min in elution buffer before boiling in SDS sample buffer. For abrogation of protein-protein interactions, beads were additionally washed 3 times with 0.1 M Na 2 CO 3 at pH 11 (8, 9) , solubilized in elution buffer, and boiled in SDS sample buffer before SDS/PAGE and Western blotting.
Immunocytochemistry. Primary cultures of hippocampal neurons were prepared as described, and DIV11-15 neurons were fixed in 4% (wt/vol) PFA/4% (wt/vol) sucrose (10 min) and washed in PBS before permeabilization with 0.25% Triton X-100 (5 min). Unspecific binding sites were blocked with 3% (wt/vol) BSA (Applichem) for 1 h, and cells were incubated with primary antibodies overnight at 4°C. Cells were washed three times in PBS and incubated with secondary antibodies for 1 h, washed extensively, and mounted in Aqua Poly Mount (Polysciences). For labeling surface populations of GluA2 containing AMPAtype glutamate receptors or N-cadherin, DIV11-13 hippocampal neurons were incubated with the respective primary antibodies (final concentrations as indicated in antibody section) for 2 h at 4°C under nonpermeabilized conditions. Staining with secondary antibodies was carried out as described earlier. Microscopy analysis was carried out with an upright Laser-scanning Confocal Microscope Fluoview FV1000 with Olympus Fluoview Software Version 2.1.b (Olympus) or with an inverted Leica TCS-SP2 laser scanning confocal microscope (Leica Microsystems). For triplelabeling studies, a sequential scanning mode was used.
Electron Microscopy. Mice were deeply anesthetized and transcardially perfused with 4% (wt/vol) PFA and 0.1% (wt/vol) glutaraldehyde in phosphate buffer at pH 7.2. For postembedding immunogold labeling, small pieces of cryoprotected hippocampus (2.3 M sucrose) were mounted on specimen holders and immersed in liquid nitrogen. Ultrathin sections (70 nm) were then cut and labeled according to a previously described method (10) .
Briefly, sections were collected on Carbon-Formvar-coated copper grids (Science Services GmbH). Antibodies, rabbit antiGluA2 (1:100; Chemicon) and mouse anti-N-cadherin (1:100; BD Biosciences), were recognized with 10-nm and 15-nm large protein A gold secondary antibody, respectively (purchased from
and mouse anti-N-cadherin (1:100; BD Biosciences), which were sequentially applied, and each antibody was separately labeled with 10-nm and 15-nm large protein A gold particles, respectively. In parallel, four independent control labeling procedures were performed in which no antibody, rabbit anti-GluA2, mouse antiGluA2 alone, or mouse anti-N-cadherin alone followed by 10-nm and 15-nm large protein A gold particles were applied. Ultrathin sections were examined, focusing on CA1 hippocampal neurons using a Zeiss EM 902 (Carl Zeiss). For quantitative studies only, rabbit anti-GluA2 and mouse anti-N-cadherin signals were analyzed. To this end, images of the Golgi apparatus were acquired, and the whole field of view at a 50,000× magnification was analyzed for 10-nm and 15-nm gold particles.
Surface Biotinylation Assay. HEK293 cells were transfected as described and, for 18 h posttransfection, were incubated for 20 min at 4°C with Hepes buffer (135 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM Hepes at pH 7.4, 15 mM glucose) containing 1 mM biotinamido-hexanoic acid 3-sulfo-N-hydroxysuccinimid-ester sodium salt (Sigma). For depolymerization of microtubules, 1 μM Nocodazole (Sigma) in 0.1% DMSO or 0.1% DMSO only was applied and incubated for 30 min at 37°C before the biotin reagent was added. The remaining biotin reagent was quenched by application of 100 mM glycine in Hepes buffer (twice for 20 min at 4°C).
Because low temperature is known to inhibit membrane trafficking and endocytosis, biotinylated cell surface expressed molecules remain at the plasma membrane during these incubations (11) . Cells were then washed with ice-cold PBS and harvested in PBS containing 1% Triton X-100 with freshly added protease inhibitor mixture (Roche) and 1 mM PMSF. After 30 min of lysis on ice, followed by a brief centrifugation step at 1,000 × g (5 min, 4°C), 30 μL of the supernatants were loaded on a gel to evaluate the total amount of N-cadherin or GluA2 posttransfection. In the case of equal N-cadherin or GluA2 total amounts, supernatants were added to 40 μL equilibrated magnetic streptavidin beads (Dynabeads Myone TM Streptavidin C1; Invitrogen). Beads were incubated with supernatants for 4 h at 4°C on a rotation wheel, washed three times with IP buffer (150 mM NaCl, 50 mM Tris at pH 7.5, 5 mM MgCl 2 ) containing 1% Triton X-100, and collected and boiled in a SDS sample buffer before SDS/PAGE and Western blot analysis.
Time-Lapse Video Microscopy. Primary hippocampal neurons were prepared as described and cultured on 22-mm coverslips. Neurons were transfected at DIV10-11 through a calcium phosphate coprecipitation method, as described, and used for live cell imaging experiments at DIV13-14. Images were acquired at an upright microscope (Nikon Instruments) combined with Spinning Disk (Yokogawa) live cell confocal (SDC) technology (Visitron Systems). SDC was combined with two charge-coupled device electron microscopy cameras (Hamamatsu Photonics) and equipped with an optical image splitter for simultaneous dual image acquisition.
For single-channel live imaging (mRFP-NCAD), a 561-nm laser was used; images were taken at intervals of every 1 s for a duration of 5-10 min. For double-channel recordings (mRFP-NCAD and GFP-GluA2), 488-nm and 561-nm lasers were simultaneously used, and images were taken at intervals of every 3 s for a duration of 5 min. For image acquisition, a 60× objective (Nikon Instruments) was used. Cells at the microscope stage were kept in Primary Neuronal Basal Media (Lonza Group Ltd) and were temperature-(37°C) and CO 2 -controlled (5%), using a live imaging chamber (Visitron Systems). Images at the microscope stage were acquired using the VisiView software (Visitron Systems), and image stacks were subsequently loaded into MetaMorph 7.1 (Universal Imaging) or Volocity 6.1.1 (Improvision; Perkin-Elmer) for analysis of fluorescent puncta. The percentage of mobile/immobile mRFP-NCAD particles on coexpression of GFP or GFP-KIF5CΔMD was calculated using manual and automated particle tracking analysis (Volocity 6.1.1) and normalized on the total amount of particles. For quantification of the percentages of cotransported GFP-GluA2/mRFP-NCAD, the number of mobile mRFP-NCAD particles that comigrated with GFP-GluA2 was divided by the total amount of mobile mRFP-NCAD particles. Tracking was performed by using MetaMorph 7.1 software (Universal Imaging), and cotransported particles were analyzed from image stacks and through manual analysis of the respective kymographs.
Image Processing and Statistical Analysis. For the evaluation of relative Western blot signal intensities, films were scanned with a resolution of 600 dpi, and signals were subsequently analyzed using the Image J, version 1.38, analysis software (National Institutes of Health). Signal intensities were then normalized compared with loading control signals for immunoblots. Statistical analysis was performed with SigmaPlot Version 10 (Systat Software Inc) and Microsoft Excel. Statistical significance was evaluated with the Student t test. All values from quantitative data are reported as mean ± SEM from n independent experiments. Error bars represent the SEM.
Fluorescence imaging was carried out with either an upright Laser-scanning Confocal Microscope Fluoview FV1000 with Olympus Fluoview Software Ver. 2.1.b (Olympus) or an inverted Leica TCS-SP2 laser scanning confocal microscope (Leica Microsystems), using a 63× objective. For simultaneous multiple-channel fluorescence, images were taken in a sequential channel recording mode. Confocal images from multiple individual cells used for statistical analysis were obtained using identical photomultiplier values throughout each experiment. All experiments were replicated at least three times, using different culture preparations.
Images were saved as overlay TIF-files and further processed off-line and analyzed using MetaMorph 7.1 (Universal Imaging). First, to differ between soma and neurites, regions of interest (ROIs) were defined throughout multiple image acquisition frames using the ROI tool. The overlay TIF files were then separated into green and red channels, using the color separate function, and ROIs were transferred from the overlay to each channel, using the transfer region function to define identical ROIs. For the definition of image thresholds, brightness was adjusted using the inclusive thresholding state function. Fluorescence intensity, size, and cluster number measurements were performed using the integrated morphometry analysis function within MetaMorph to assess the average signal intensity, total signal intensity, average cluster size, and cluster number of identically defined ROIs for each channel. Using the colocalization tool within Metamorph assessed the area of colocalization. For distribution studies, surface labeling analysis, or colocalization measurements, one or two neurites were randomly chosen from the distal parts of a neuron.
Statistical analysis was performed with SigmaPlot Version 10 (Systat Software Inc) and Microsoft Excel. Statistical significance was evaluated with the Student t test, according to the following definition: P > 0.05, not significant; P = 0.01-0.05, significant (*); P = 0.001-0.01, very significant (**); and P < 0.001, highly significant (***). All values from quantitative data are reported as mean ± SEM from n independent experiments. Error bars represent the SEM. indicates that XFP-fusions of GRIP1, NCAD, and GluA2 are frequently targeted to spine and shaft synapses (arrows). Rab6A was used to mark KIF5-driven Golgiderived vesicles that traffic to the cell periphery (16) . GFP-KIF5C and, notably, also the XFP-fusion proteins of GRIP1, NCAD, and GluA2 show a good degree of colocalization with Rab6A puncta (arrows), indicating that XFP-fusion proteins used in this study show an intracellular distribution similar to the endogenous proteins. Boxed regions are shown at higher magnification. (Scale bars, 20 μm for overviews and 5 μm for boxes.) (F-J) Hippocampal neurons, transfected at DIV9-12, were allowed 18 h expression of the indicated XFP-fusion proteins before immunostaining of their respective endogenous counterparts. High degrees of colocalization between the endogenous and XFP-fusion proteins used in this study are observed (arrows). Note that only a very few endogenous protein signals do not colocalize with their fusion protein counterpart. In addition to the controls provided here, other studies also reported a similar distribution of these XFP-fusion proteins compared with their endogenous counterparts (17) (18) (19) (20) . (Scale bar, 5 μm.) (K and L) Quantitative analysis of XFP-fusion protein distribution and expression compared with endogenous proteins. The relative numbers of particles per dendrite and the relative area per particle were compared between untransfected and transfected cells on immunostaining with antibodies (AB), as indicated. (K) The relative numbers of particles per dendrite segment are similar for most constructs between transfected and untransfected cells, suggesting a similar particle distribution. GRIP1 AB: mRFP-GRIP1, 1.19 ± 0.10 (23 cells); GFP-GRIP1, 1.04 ± 0.07 (28 cells); and untransfected, set to 1 (39 cells). NCAD AB: mRFP-NCAD, 1.21 ± 0.08 (48 cells), and untransfected, set to 1 (28 cells). GluA2 AB: GFP-GluA2, 1.12 ±0.05 (35 cells), and untransfected, set to 1 (33 cells). KIF5C AB: GFP-KIF5C, 1.53 ± 0.11 (23 cells) , and untransfected, set to 1 (22 cells). (L) The relative areas per particles are increased in transfected compared with untransfected cells, indicative of overexpression of XFP-fusion proteins. GRIP1 AB: mRFP-GRIP1, 1.64 ± 0.14 (23 cells); GFP-GRIP1, 1.77 ± 0.12 (28 cells); and untransfected, set to 1 (39 cells). NCAD AB: mRFP-NCAD, 1.79 ± 0.13 (48 cells), and untransfected, set to 1 (28 cells). GluA2 AB: GFP-GluA2, 1.37 ± 0.11 (34 cells), and untransfected, set to 1 (33 cells). KIF5C AB: GFP-KIF5C, 1.81 ± 0.16 (23 cells), and untransfected, set to 1 (22 cells). (M) Quantitative analysis of colocalization levels between endogenous and XFP-fusion protein signals: mRFP-GRIP1 with GRIP1, 92.29 ± 1.88; mRFP-NCAD with NCAD, 90.26 ± 1.45; GFP-GluA2 with GluA2, 91.03 ± 1.18; GFP-GRIP1 with GRIP1, 89.17 ± 1.64; and GFP-KIF5C with KIF5C, 81.67 ± 2.29. Numbers of cells as indicated. Data are represented as mean ± SEM. The Student t test (***P < 0.001; **P < 0.01) was used for statistical analysis. Movie S1
